Malaria News and Research

Latest Malaria News and Research

Ajoene in garlic prevents bacteria from destroying white blood cells

Aggressive multi-resistant infections constitute an increasing health problem all over the world. Bacteria are developing resistance at an alarming pace, so new pharmaceuticals that can combat this threat are in great demand.

19 Feb 2014

Study identifies seven new genetic regions associated with type 2 diabetes

Seven new genetic regions associated with type 2 diabetes have been identified in the largest study to date of the genetic basis of the disease.

9 Feb 2014

Researchers design new vaccine for human-infecting respiratory syncytial virus

Vaccines are the safest, cheapest and most effective way to protect against infectious diseases. But to make a good one is still a challenge, and traditional approaches are now stretched to the limit while fatal diseases, like HIV and malaria, remain without vaccine.

6 Feb 2014

Fraunhofer USA receives FDA clearance for IND malaria TBV that targets Pfs25 antigen

Fraunhofer USA Center for Molecular Biotechnology (FhCMB) announced today that clearance was obtained from the U.S. Food and Drug Administration (FDA) for an investigational new drug (IND), Fraunhofer's plant-derived malaria transmission-blocking vaccine (TBV), which targets the Pfs25 antigen, to proceed into the clinic in a Phase 1 safety and immunogenicity study.

5 Feb 2014

Keystone Symposia to convene conference focusing on the science of malaria eradication

Keystone Symposia, in collaboration with MESA (Malaria Eradication Scientific Alliance), is convening its first conference in Mexico – on "The Science of Malaria Eradication" at the Fiesta Americana Hotel in Merida, Yucatan. The four-day conference begins Sunday evening, February 2, 2014 and is part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation, which has also funded travel awards for investigators from malaria-endemic countries to attend. The conference will gather experts from 37 countries.

31 Jan 2014

Novel approaches could lead researchers to develop new vaccine for East Coast fever, malaria

The Nairobi-based International Livestock Research Institute announced today that a global consortium supported by the Bill & Melinda Gates Foundation has been formed to develop a new vaccine against a disease that's devastating cattle herds in sub-Saharan Africa. This highly advanced cattle vaccine project could also help malaria and cancer research in humans.

31 Jan 2014

Neuroscientist, researchers receive Vilcek Prize in Biomedical Science

The Vilcek Foundation is pleased to name Thomas M. Jessell as the winner of the 2014 Vilcek Prize in Biomedical Science. Awarded annually, the Vilcek Prizes honor the contributions of immigrants to the American arts and sciences, and include $100,000 cash awards.

30 Jan 2014

Exposure to DDT may increase likelihood of developing Alzheimer's disease later in life

Exposure to DDT may increase the likelihood of developing Alzheimer's disease later in life, a study with researchers at UT Southwestern Medical Center suggests. While previous studies have linked chronic diseases such as cancer and diabetes to DDT, this is the first clinical study to link the U.S.-banned pesticide to Alzheimer's disease.

30 Jan 2014

Researchers identify unique area of human brain associated with cognitive powers

Oxford University researchers have identified an area of the human brain that appears unlike anything in the brains of some of our closest relatives.

29 Jan 2014

Exposure to pesticide may increase risk of Alzheimer's disease, say researchers

Scientists have known for more than 40 years that the synthetic pesticide DDT is harmful to bird habitats and a threat to the environment.

27 Jan 2014

USF Health receives $2.1M grant to study on new factors required for growth of malaria-related parasites

Animal cells similar to those of humans contain a "control room," called the centrosome, which regulates cell replication. Disrupt this core hub and you kill cell division.

24 Jan 2014

Inovio Pharmaceuticals unveils new DNA-based cytokine immune activator

Inovio Pharmaceuticals, Inc. today unveiled that the company has developed a new DNA-based cytokine immune activator, interleukin -33 (IL-33), that in combination with optimized DNA vaccines delivered by electroporation increased the potency and efficacy of the therapeutic response to the DNA vaccines in a preclinical study.

23 Jan 2014

Anti-malaria drug combination may help prevent pregnancy complications in women with lupus

An anti-malaria drug combination might be useful in helping to prevent pregnancy complications in women with lupus and the related disorder antiphospholipid syndrome, Yale School of Medicine researchers have found in a new study published in the American Journal of Reproductive Immunology.

23 Jan 2014

Researchers find new candidate that may help combat malaria

Two of the most urgent challenges for scientists are the battles against food shortages and infectious diseases like malaria. Unfortunately, both the herbicides used to protect plants and the anti-infectives that shield us from disease rapidly lose their effectiveness as the target organisms develop resistance. In order to benefit both fields at once, scientists tested lead compounds from agrochemical research against infectious germs as well.

21 Jan 2014

Dihydroartemisinin-piperaquine more effective than artemether-lumefantrine in treating malaria

'Dihydroartemisinin-piperaquine is more effective than artemether-lumefantrine, and has fewer side effects than artesunate-mefloquine' concludes a systematic review published by the Cochrane Infectious Disease Group, hosted by LSTM.

21 Jan 2014

LUMC receives grant for research into influence of 'the family' on child mortality, fertility and life expectancy

Radboud University historians and ageing researchers from Leiden University Medical Center (LUMC) will be receiving a grant of over 800,000 euros for research into the influence of 'the family' on child mortality, fertility and life expectancy over the last two hundred years.

21 Jan 2014

Researchers explore new strategy to defeat drug-resistant strains of malaria

Malaria is one of the most deadly infectious diseases in the world today, claiming the lives of over half a million people every year, and the recent emergence of parasites resistant to current treatments threatens to undermine efforts to control the disease. Researchers are now onto a new strategy to defeat drug-resistant strains of the parasite. Their report appears in the journal ACS Chemical Biology.

15 Jan 2014

Malaria News and Research

Latest Malaria News and Research

Ajoene in garlic prevents bacteria from destroying white blood cells

Study identifies seven new genetic regions associated with type 2 diabetes

Researchers design new vaccine for human-infecting respiratory syncytial virus

Fraunhofer USA receives FDA clearance for IND malaria TBV that targets Pfs25 antigen

Keystone Symposia to convene conference focusing on the science of malaria eradication

Novel approaches could lead researchers to develop new vaccine for East Coast fever, malaria

Neuroscientist, researchers receive Vilcek Prize in Biomedical Science

Exposure to DDT may increase likelihood of developing Alzheimer's disease later in life

Researchers identify unique area of human brain associated with cognitive powers

Exposure to pesticide may increase risk of Alzheimer's disease, say researchers

USF Health receives $2.1M grant to study on new factors required for growth of malaria-related parasites

Inovio Pharmaceuticals unveils new DNA-based cytokine immune activator

Anti-malaria drug combination may help prevent pregnancy complications in women with lupus

Researchers find new candidate that may help combat malaria

Dihydroartemisinin-piperaquine more effective than artemether-lumefantrine in treating malaria

LUMC receives grant for research into influence of 'the family' on child mortality, fertility and life expectancy

Researchers explore new strategy to defeat drug-resistant strains of malaria

Study provides details to help scientists design better vaccines for Plasmodium vivax

Astellas, ClearPath announce strategic partnership to develop vaccine for infectious diseases

Discovery opens new pathways for treatment of toxoplasmosis and malaria

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Malaria News and Research

Latest Malaria News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in